Better biofactories

STAFFORDSHIRE, U.K.—Cobra Biomanufacturing developed a method that provides cleaner biologics

Randall C Willis
STAFFORDSHIRE, U.K.—Increasingly, scientists are using bacteria to produce a variety of products as therapeutics as well as for other applications. Unfortunately, endogenous proteins and metabolic products within the microbes can contaminate and seriously compromise the desired product. With an eye to eliminating the genes that produce these contaminants, scientists at Cobra Biomanufacturing developed a method that offers higher efficiencies than random recombination and does not rely on exogenous recombinases or transposases. They presented their work in Applied and Environmental Microbiology (2006, 72, 2520-2525).
 
The researchers relied on Xer recombinases, enzymes that naturally occur in most bacterial strains, to remove ("Xer"-cise) target genes in E. coli and B. subtilis strains, and used PCR to confirm their results. With E. coli, they deleted a gene responsible for adding an immunogenic myristoyl group to lipid A and thereby reduced the endotoxicity of the microbe for plasmid DNA production. Similarly, in B. subtilis, they were able to delete the genes responsible for proteases that degrade secreted recombinant proteins.
 
The researchers expect that their technique will become more widely applicable as scientists discover more microbes that carry Xer-sensitive recombination sequences and foresee the possible application of this technology in selective gene removal in eukaryotic organisms.

Randall C Willis

Subscribe to Newsletter
Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

November 2022 Issue Front Cover

Latest Issue  

• Volume 18 • Issue 11 • November 2022

November 2022

November 2022